MNPK BIOTIKI Report issue

Foundation
Founded: Moscow Russian Federation (1991)

Organization Overview

First Clinical Trial
2017
NCT03353441
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

OOO MNPK BIOTIKI

Active Ingredients

Drugs in Other Trials (1)

glycine (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1